Drs Paget and Schwartzman discuss both rare and common comorbidities, and the latest strategies to prevent their damaging effects.

Dr Jonathan Kay discusses highlights from the 2016 American College of Rheumatology annual meeting.

Dr Whyte warns us to use caution when prescribing opioids with benzodiazepines. Or better yet, avoid their combined use if possible.

Dr Peter Yellowlees discusses opioid agonist treatment for pharmaceutical opioid-dependent people.

Two recent studies offer encouraging results in treating giant cell arteritis.

Dr Paget discusses the potential impact of biosimilars in rheumatology and some of the unanswered questions about their use.

Dr Kay describes a case that illustrates the pitfalls of focusing on one set of symptoms in a patient with a very complex history.

Dr John Kay discusses an interesting case of a patient with rheumatoid arthritis and flu-like symptoms.

A team of ophthalmologists and HIV specialists were not sure what to do with this complicated patient, so they turned to the rheumatologist to help with a treatment decision.

What is the fallout from celebrities championing causes in health and illness? Dr Jeffrey A. Lieberman discusses negatives and positives.